Pear Therapeutics

John Harris

Jazz Venture Partners

John is a seasoned investor, operating executive and corporate director and brings to JAZZ significant experience founding, funding and developing early-stage life sciences and technology companies. He has served as a founder, executive, corporate director, and investor to numerous companies, and has held executive in residence positions at Mayfield Fund and Versant Ventures and an Advisory Board position with Arboretum Ventures.

Prior to JAZZ, John was the founder, President and CEO of NeuroVista, a Seattle-based medical device company pioneering new technologies for the management and treatment of epilepsy. NeuroVista was acquired by Cyberonics in 2013 (NASDAQ: CYBX). John was also a founder and the Vice President of Marketing and Business Development at Northstar Neuroscience, which went public in 2006 (NASDAQ: NSTR) and was subsequently acquired by St. Jude Medical (NYSE: STJ). Prior to founding Northstar, he was a founder of Heartstream, a company that revolutionized the treatment of sudden cardiac arrest with uniquely designed external defibrillators that remain the market leader and can be found in airports, airplanes, stadiums, public buildings and many other locations. Heartstream went public in 1996, was subsequently acquired by Hewlett-Packard (NYSE: HPQ).

John is also a cofounder of ClearFlow, MDI Partners, and VenX, and has held board positions with Setpoint Medical, Mirador Biomedical, ExoLabs and Norfil Manufacturing.

John holds a BS in industrial engineering from Stanford University and an MBA from Northwestern University’s Kellogg School of Management.